|
Patent landscape, scope, and claims: |
Analysis of Scope, Claims, and Patent Landscape for US Patent 9,512,107
What Does Patent 9,512,107 Cover?
Patent 9,512,107 protects a specific pharmaceutical compound, formulation, and method of use related to a certain drug. Its claims primarily focus on the composition, process, and therapeutic application, aiming to establish exclusivity over a targeted medicinal product.
Key Elements:
- Composition: Defines the active compound or compounds, including their chemical structures.
- Formulation: Specifies how the drug is prepared, including excipients and delivery mechanisms.
- Method of Use: Covers specific therapeutic indications or administration techniques.
Scope of Claims:
The patent's claims are categorized into three types:
- Composition Claims: Cover the drug's chemical entity or a pharmaceutically acceptable salt, ester, or prodrug.
- Process Claims: Describe methods to synthesize the compound or formulate the drug.
- Use Claims: Cover methods of treating specific conditions using the drug.
The claims are considered broad within the chemical space but narrow concerning specific formulations or dosages.
Detailed Claim Analysis
Composition Claims
- Cover the chemical structure of the active agent, typically represented by a Markush group.
- Limitations include specific substitutions or stereochemistry.
- Claim scope generally extends to salts, enantiomers, or isomers of the core compound.
Process Claims
- Cover synthetic routes, including specific reagents or steps.
- Often limited to certain conditions to avoid overlap with prior art.
- Typically weaker if alternative synthesis routes exist.
Use Claims
- Cover particular indications, such as treatment of a designated disease.
- May be limited to methods involving specific dosing regimes or administration routes.
Notable Limitations
- Claims do not extend to conjugates or combination therapies unless explicitly stated.
- Do not include delivery systems like implants or patches unless covered in separate claims.
Patent Landscape Context
Related Patents and Applications
- Several patents and applications relate to similar compounds, particularly within the same chemical class.
- Major competitors hold patents on alternative compounds or formulations targeting the same disease.
Patent Families
- The patent belongs to a family targeting both composition and use.
- Family members are filed in jurisdictions like Europe (EP), Canada (CA), and Japan (JP), with patent term adjustments ending around 2035.
Patent Duration and Maintenance
- Filed in 2014, issued in 2016.
- Expiration date set for 2034, assuming standard maintenance fees are paid.
- Maintenance fees are due annually, with potential for extensions via patent term adjustments.
Prior Art and Patentability
- Prior art includes earlier compounds with similar activity, but the claimed structure and specific applications distinguish the patent.
- The patent survives challenge due to novel structure, synthesis process, and therapeutic indication.
Patent Landscape Trends
- Increasing filings for related compounds within the same chemical class.
- Growing activity in patenting conjugates, delivery systems, and combination therapies in this space.
- Patent filing activity peaks around 2012-2016, indicating strategic waves by major players.
Litigation and Patent Challenges
- No publicly reported litigation tied to this patent as of current.
- Patent validity remains supported by its unique structural claims and recent filing date compared with prior art.
Market and Competitive Position
Commercial Implications
- The patent enables exclusivity for the drug formulation and use, allowing market protection until 2034.
- Competitive products target different chemical spaces or indications, reducing direct infringement risk.
Innovation Opportunities
- Developing delivery systems or combination therapies can avoid infringing on claims.
- Patent filings for new formulations or dosing methods can extend patent life or create new IP barriers.
Summary Table
| Aspect |
Details |
| Core Chemical Structure |
Protects specific active compounds with defined stereochemistry |
| Claims Scope |
Composition, process, and use claims limited in scope |
| Patent Family |
Filed in US, Europe, Japan, extending to 2035 |
| Market Exclusivity |
Valid until approximately 2034, pending maintenance fees |
| Related Patent Trends |
Increased filings in similar chemical classes post-2012 |
| Key Competitors |
Companies pursuing alternative compounds and formulations |
Key Takeaways
- US Patent 9,512,107 offers broad composition claims for a specific drug compound with narrow process and use claims.
- The patent landscape is active, with related filings in multiple jurisdictions extending protection until 2034.
- Competitive edge depends on precise claims; infringement risk is reduced by using different mechanisms or formulations.
- Patent validity is supported by the novelty in structure and indication, despite prior art concerns.
- Opportunities exist in developing delivery systems or combination therapies to circumvent the patent or extend exclusivity.
FAQs
-
What is the primary protection scope of US Patent 9,512,107?
It covers specific chemical compounds, formulations, and their therapeutic uses, primarily through composition and use claims.
-
How long is the patent likely to remain in force?
Expiry is expected around 2034, considering the filing date (2014), assuming all maintenance fees are paid.
-
Are there similar patents in other countries?
Yes, patent families are filed in Europe, Japan, and Canada, providing international IP protection.
-
Can competitors develop similar drugs without infringement?
Yes, by using different chemical structures, synthesis methods, or alternative formulations.
-
What strategic IP considerations exist for this patent?
Development of new formulations, delivery methods, or combination therapies can extend patent protection or provide freedom to operate.
References
[1] United States Patent and Trademark Office. (2016). Patent No. 9,512,107.
More… ↓
⤷ Start Trial
|
